248 related articles for article (PubMed ID: 18266785)
1. Changing landscape of invasive aspergillosis in allogeneic stem cell transplant recipients.
Jantunen E; Nihtinen A; Anttila VJ
Transpl Infect Dis; 2008 Jun; 10(3):156-61. PubMed ID: 18266785
[TBL] [Abstract][Full Text] [Related]
2. Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?
Jantunen E; Anttila VJ; Ruutu T
Bone Marrow Transplant; 2002 Dec; 30(12):925-9. PubMed ID: 12476286
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
[TBL] [Abstract][Full Text] [Related]
4. Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease.
Boutboul F; Alberti C; Leblanc T; Sulahian A; Gluckman E; Derouin F; Ribaud P
Clin Infect Dis; 2002 Apr; 34(7):939-43. PubMed ID: 11880959
[TBL] [Abstract][Full Text] [Related]
5. Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation.
Leithauser M; Kahl C; Aepinus C; Prall F; Maruschke M; Riemer H; Wolff D; Jost K; Hilgendorf I; Freund M; Junghanss C
Transpl Infect Dis; 2010 Jun; 12(3):251-7. PubMed ID: 20002357
[TBL] [Abstract][Full Text] [Related]
6. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ
Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.
Cordonnier C; Ribaud P; Herbrecht R; Milpied N; Valteau-Couanet D; Morgan C; Wade A;
Clin Infect Dis; 2006 Apr; 42(7):955-63. PubMed ID: 16511759
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation.
Thursky K; Byrnes G; Grigg A; Szer J; Slavin M
Bone Marrow Transplant; 2004 Jul; 34(2):115-21. PubMed ID: 15156166
[TBL] [Abstract][Full Text] [Related]
9. Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.
Hebart H; Löffler J; Meisner C; Serey F; Schmidt D; Böhme A; Martin H; Engel A; Bunje D; Kern WV; Schumacher U; Kanz L; Einsele H
J Infect Dis; 2000 May; 181(5):1713-9. PubMed ID: 10823773
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
Ito JI; Chandrasekar PH; Hooshmand-Rad R
Bone Marrow Transplant; 2005 Nov; 36(10):873-7. PubMed ID: 16113663
[TBL] [Abstract][Full Text] [Related]
11. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
[TBL] [Abstract][Full Text] [Related]
12. Invasive aspergillosis: diagnosis, prophylaxis and treatment.
Del Bono V; Mikulska M; Viscoli C
Curr Opin Hematol; 2008 Nov; 15(6):586-93. PubMed ID: 18832929
[TBL] [Abstract][Full Text] [Related]
13. [Aspergillosis in stem cell transplant recipients].
Jantunen E
Duodecim; 2001; 117(17):1715-9. PubMed ID: 12181934
[No Abstract] [Full Text] [Related]
14. Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15-year experience.
Crassard N; Hadden H; Pondarré C; Hadden R; Galambrun C; Piens MA; Pracros JP; Souillet G; Basset T; Berthier JC; Philippe N; Bertrand Y
Transpl Infect Dis; 2008 Jun; 10(3):177-83. PubMed ID: 18331389
[TBL] [Abstract][Full Text] [Related]
15. Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis.
Kontoyiannis DP; Ratanatharathorn V; Young JA; Raymond J; Laverdière M; Denning DW; Patterson TF; Facklam D; Kovanda L; Arnold L; Lau W; Buell D; Marr KA
Transpl Infect Dis; 2009 Feb; 11(1):89-93. PubMed ID: 18983417
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
17. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
[TBL] [Abstract][Full Text] [Related]
18. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders.
Hovi L; Saxen H; Saarinen-Pihkala UM; Vettenranta K; Meri T; Richardson M
Pediatr Blood Cancer; 2007 Jan; 48(1):28-34. PubMed ID: 16395687
[TBL] [Abstract][Full Text] [Related]
19. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.
Halliday C; Hoile R; Sorrell T; James G; Yadav S; Shaw P; Bleakley M; Bradstock K; Chen S
Br J Haematol; 2006 Feb; 132(4):478-86. PubMed ID: 16412020
[TBL] [Abstract][Full Text] [Related]
20. Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.
Oshima K; Kanda Y; Asano-Mori Y; Nishimoto N; Arai S; Nagai S; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
J Antimicrob Chemother; 2007 Aug; 60(2):350-5. PubMed ID: 17584800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
